Audio

COSENTYX (secukinumab) for the Ongoing Management of Adult Patients with Moderate to Severe Plaque Psoriasis and Active Psoriatic Arthritis

This Product Theater, sponsored by Novartis Pharmaceuticals, from the SDPA 14th Annual Fall Dermatology Conference 2016, held November 3 – 6 in Las Vegas, Nevada, titled “COSENTYX (secukinumab) for the Ongoing Management of Adult Patients with Moderate to Severe Plaque Psoriasis and Active Psoriatic Arthritis” was presented by Clive Liu, MD.




Some of Our Sponsors